NCM
CCXI

Next Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Next Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-301
Closed -$3K – 853
2019
Q2 		$3K Buy
+301
New +$3.48K ﹤0.01% 750

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Next Capital Management's CCXI Position: Q3 2019 in Review

Next Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2019, closing a stake of 301 shares — an estimated $3K sold.

Next Capital Management first reported a position in CCXI in Q2 2019 and held it in 1 quarter. The position peaked at $3K in Q2 2019. 100 funds tracked by Wall St. Rank hold CCXI as of Q3 2019.

  • Next Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2019 after selling out during the quarter.
  • Next Capital Management sold 301 ChemoCentryx, Inc. shares in Q3 2019, an estimated $3K.
  • Next Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 1 quarter.
  • Next Capital Management's ChemoCentryx, Inc. position peaked at $3K in Q2 2019.
  • 100 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2019.

Based on Next Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.